OpenBilldrug price receipt

NADAC week of 2026-10-14

COLESEVELAM HCL 3.75 G PACKET

For 1 unit (EA)

Pharmacies pay

$2.70 filed

1 × $2.70422 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$1.04 filed

1 × $1.04079 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.38× estimated

Medicare paid 62% less than pharmacies pay.

Part D averages every strength and form sold under “Colesevelam HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$8.11 estimated

$2.70 + $0.41 (15%) + $5.00 fee per fill = $8.11

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

COLESEVELAM HCL 3.75 G PACKET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as colesevelam hydrochloride.

FDA gives its dosage form as powder, for suspension and its route as oral.

Its labelers, the companies named on the label, are Ascend Laboratories, LLC and Glenmark Pharmaceuticals Inc.,USA.

FDA’s Established Pharmacologic Class for it is Bile Acid Sequestrant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.70 for 1 unit (EA) (1 × $2.70422 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 3 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name colesevelam hydrochloride with COLESEVELAM HCL 3.75 G PACKET.

ProductPharmacies pay per unitMedicare per unit
COLESEVELAM 625 MG TABLET
generic · tablet, film coated / tablet
$0.26171 per EA filed
eff. 2026-09-23
$1.04079 per EA filed
Part D 2024 average
COLESEVELAM HCL 3.75 G PACKET this page
generic · powder, for suspension
$2.70422 per EA filed
eff. 2026-09-23
$1.04079 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $2.70422 per EA filed.

Of the 5 other products in FDA’s Bile Acid Sequestrant class priced per EA, 0 have a higher middle NADAC price and 5 a lower one. The one in the middle is CHOLESTYRAMINE LIGHT PACKET, at $0.83267 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $1.04 for 1 unit (EA), at an average of $1.04079 per EA in 2024 (2024-01-01 to 2024-12-31) for “Colesevelam HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 262,604 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for COLESEVELAM HCL 3.75 G PACKET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Colesevelam HCl / Colesevelam HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 2 of its 3 NDCs (it does not list the other one) as dosage form “POWDER, FOR SUSPENSION” with route “ORAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.